4.1 /5 • 8 oceny

Opis

0.0 / 5

Jakość

4.1 / 5

Stosunek jakości do ceny

3.9 / 5

Oceny 8

Świetna

38 %

Dobra

50%

Średnia

Zła

12%

Bardzo zła

BOSANO Laurette 2021-08-20

Très efficace, plus que les gouttes!

BENEDETTO Jean Yves 2021-08-08

trop chère pour sa réelle efficacité ...

Jose Aurelio Pascual Ferrero 2021-06-07

La verdad que tal y como lo describen no se corresponde con los resultados en mi cuando lo he necesitado.

DE MAISTRE Amira 2021-03-02

En revanche la crème très efficace , enlève l'insupportable de la douleur

BRIAN Dal Zilio 2020-11-20

Funziona veramente,dopo solo quattro aplicazioni il dolore era gia a 50% in meno.

BENCE Yves 2020-10-23

Parfait pour zones algiques localisées ; cher pour 15ml

Nicole Fowler 2020-05-27

Excellent produit pour soulager des douleurs légères

MELIN Christiane 2020-02-12

AYANT UNE SPONDYLARTHRITE ANKYLOSANTE, C'EST LE SEUL BAUME QUI ME SOULAGE UN PEU.

Bibliografia

Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review. JAMA. 2015;313:2474–83
Rog DJ, Nurmikko TJ, Friede T, Young CA. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology. 2005;65:812–9
Venance L, Maldonado R, Manzoni O. Le système endocannabinoïde central. Med Sci (Paris) 2004 ; 20 : 45-53.
Hillard CJ. Endocannabinoids and vascular function. J Pharmacol Exp Ther. 2000;294:27–32.
Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimarães FS. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos Trans R Soc Lond B Biol Sci. 2012;367:3364–78.
Bergamaschi MM, Queiroz RHC, Chagas MHN, de Oliveira DCG, De Martinis BS, Kapczinski F, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology. 2011;36:1219–26.
Iuvone T, Esposito G, Esposito R, Santamaria R, Di Rosa M, Izzo AA. Neuroprotective effect of cannabidiol, a non-psychoactive componentpCannabis sativa, on ß-amyloid-induced toxicity in PC12 cells. J Neurochem. 2004;89:134–41.
Dougrul A, Gul H, Akar A, Yildiz O, et al. Topical cannabinoid antinociception: synergy with spinal sites. Pain 2003;105:11-16.
Bereiter DA, Bereiter DF, Hirata H. Topical cannabinoid agonist, WIN55,212-2, reduces corneaevoked trigeminal brainstem activity in the rat. Pain 2002;99:547-556.
Maida, V., & Corban, J. (2017). Topical Medical Cannabis: A New Treatment for Wound Pain—Three Cases of Pyoderma Gangrenosum. Journal of Pain and Symptom Management, 54(5), 732–736. doi:10.1016/j.jpainsymman.2017.06.005
B. Palmieri, C. Laurino, M. Vadalà. A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars, Clin Ter 2019; 170 (2):e93-99. doi: 10.7417/CT.2019.2116

Zestawy komplementarne

5 gwiazdki		3
4 gwiazdki		4
3 gwiazdki		0
2 gwiazdki		1
1 gwiazdka		0